Sijin Li
-
- Atherosclerosis and Cardiovascular Diseases 4
-
- Traditional Chinese Medicine Analysis 4
-
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 4
-
- Virus-based gene therapy research 3
-
- Nanowire Synthesis and Applications 3
-
- Thyroid Cancer Diagnosis and Treatment 3
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Jiarou WangMin DuPing LiuYiru WangNan YangLong‐Qing ChenYifan ZhangJie Ding
- Partner nations
- ChinaUnited States
In The Last Decade
Sijin Li
29 papers receiving 308 citations
Peers
Comparison fields: 5 of 85
- Immunology 69
- Complementary and alternative medicine 24
- Oncology 71
- Cancer Research 37
- Molecular Biology 119
Countries citing papers authored by Sijin Li
This map shows the geographic impact of Sijin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijin Li more than expected).
Fields of papers citing papers by Sijin Li
This network shows the impact of papers produced by Sijin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijin Li. The network helps show where Sijin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sijin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 19 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 14 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 13 | |
| 15 | 2022 | 8 | |
| 16 | 2022 | 35 | |
| 17 | 2022 | 27 | |
| 18 | 2021 | 6 | |
| 19 | 2021 | 14 | |
| 20 | Immunization with beta(1)-adrenoreceptor peptide induces cardiomyopathy-like changes in rabbit hearts. | 2002 | 7 |
About Sijin Li
Sijin Li is a scholar working on Complementary and alternative medicine, Oncology and Immunology, having authored 31 papers that have together received 312 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Traditional Chinese Medicine Analysis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Virus-based gene therapy research (3 papers), Nanowire Synthesis and Applications (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Immunology (69 citations), Complementary and alternative medicine (24 citations) and Oncology (71 citations). Sijin Li has collaborated with scholars based in China and United States. Frequent co-authors include Jiarou Wang, Min Du, Ping Liu, Yiru Wang, Nan Yang, Long‐Qing Chen, Yifan Zhang, Jie Ding, Junnian Zheng and Yifan Zhang. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.